DZ Bank Aktienanleihe INN1 25.09..../ DE000DJ6N4C6 /
14/06/2024 09:08:26 | Chg.-0.01 | Bid13:39:09 | Demandez à13:39:09 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
99.63EUR | -0.01% | 99.45 Bid taille: 100,000 |
99.55 Ask la taille: 100,000 |
ING GROEP NV EO... | 12.346 - | 25/09/2024 | Call |
GlobeNewswire
14:00
Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress
GlobeNewswire
14:00
BIO-key Introduces Passkey:YOU, a Phish-resistant, Phoneless and Tokenless Biometric FIDO Passkey Au...
GlobeNewswire
14:00
Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of ...
GlobeNewswire
14:00
Spectrum Group International Announces Extension of Election Deadline for Proposed Cash Election Mer...
GlobeNewswire
14:00
Summit Nanotech and Zelandez Collaborate to Accelerate Modular Lithium Carbonation Project in South ...
GlobeNewswire
14:00
LiveOne (Nasdaq: LVO) Announces 244th Edition of LiveOne Presents as Streaming Partner for “The Game...
GlobeNewswire
14:00
ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritini...
GlobeNewswire
14:00
Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored...
GlobeNewswire
13:50
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American...
GlobeNewswire
13:30
JOYY Inc. Announces the Results of the Repurchase Right Offer for its 1.375% Convertible Senior Note...
GlobeNewswire
13:30
Cogent Biosciences Announces Additional Clinical Data from Part 1 of its Ongoing SUMMIT Trial Evalua...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page